A carregar...
Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial
BACKGROUND: Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia. Combination immunochemotherapy such as fludarabine, cyclophosphamide and rituximab is the standard first line therapy in fit patients, but there is limited evidence regarding the optimal treatment of patients after r...
Na minha lista:
Publicado no: | Trials |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5028943/ https://ncbi.nlm.nih.gov/pubmed/27645620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1581-0 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|